Platelet surface activation antigen expression at baseline and during elective angioplasty in patients with mild to moderate coronary artery disease

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 2, 1996, Pages 165-168

  Cahill, M R ^a   Macey, M G ^a   Dawson, J R ^a   Newland, A C ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Angioplasty; Coronary artery disease; Flow cytometry; Platelet activation

Indexed keywords

ADULT; AGED; ANGIOPLASTY; ANTIGEN EXPRESSION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; THROMBOCYTE MEMBRANE;

EID: 0029951813     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199603000-00013     Document Type: Conference Paper

References (15)

1. Office of Population Censuses and Surveys. Mortality Statistics 1991. HMSO, London.
2. Friedman RJ, Stemerman MB, Wenz B, et al. The effect of thrombocytopenia on experimental atherosclerotic lesion formation in rabbits. J Clin Invest 1977; 60: 1191-1201.
3. Pasternak RC, Baughman KL, Fallon JT, Block PC. Scanning electron microscopy after coronary transluminal angioplasty of normal canine coronary arteries. Am J Cardiol 1980; 45: 591-598.
4. Fuster V, Badimon L, Badmion JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1991; 326: 242-250 and 310-318. membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation 1993; 88: 37-42.
5. Fuster V, Badimon L, Badmion JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1991; 326: 242-250 and 310-318. membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation 1993; 88: 37-42.
6. Elwood PC, Renaud S, Sharp DS, et al. Ischemic heart disease and platelet aggregation: the Caerphilly collaborative heart disease study. Circulation 1991; 83: 38-44.
7. Hughes A, Daunt S, Vass G, Wickes J. In vivo platelet activation following myocardial infarction and acute coronary ischemia. Thromb Haemostas 1982; 48: 133-135.
8. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349-360.
9. Cahill MR, Macey MG, Newland AC. Fixation with formaldehyde induces expression of activation dependent platelet membrane glycoproteins. Br J Haematol 1993; 84: 527-529.
10. Rinder CS, Student LA, Bonan JL, Rinder HM, Smith BR. Aspirin does not inhibit adenosine diphosphate induced platelet α-granule release. Blood 1993; 82: 505-512.
11. Holmsen H, Kaplan KL, Dangelmaier CA. Differential energy requirements for platelet responses. A simultaneous study of aggregation, three secretory processes, arachidonate liberation, phosphatidylinositol breakdown and phosphatidate production. Biochem J 1982; 208: 9-18.
12. Cahill MR, Macey MG, Dawson JR, Newland AC. Prevention of restenosis after angioplasty. Lancet 1994; 343: 136 (letter with data).
13. EPIC investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty. New Engl J Med 1994; 330: 956-961.
14. Ghosh TK, Eis PS, Mullaney JM, Ebert CL, Gill DL. Competitive, reversible, and potent antagonism of inositol 1,4,5-triphosphate-activated calcium release by heparin. J Biol Chem 1988; 263: 11075-11079.
15. Greenbaum RA, Barradas MA, Mikhailidis DP, Jeremy JY, Evans TR, Dandona P. Effect of heparin and contrast medium on platelet function during routine cardiac catheterisation. Cardiovasc Res 1987; 21: 878-885.